Staff member Peng Jiping (front L) communicates with colleague Zeng Haijie (front R) at the laboratory of KingMed Diagnostics, a Chinese medical diagnostic testing company in Beijing, capital of China, early June 26, 2020. With 2,422 sample collection points set up at 480 venues across the capital, Beijing can now offer more than 300,000 nucleic acid tests for COVID-19 every day. (Xinhua/Ju Huanzong)
